The DOI matches its Crossref record.
The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.
Abstract
OBJECTIVES: To investigate the importance of age and other variables on the prevalence of secondary forms of hypertension in a hypertension referral center. DESIGN: Over the past 18 years 4429 patients have been referred by their physicians for a 1-day blood pressure study to investigate secondary causes of hypertension. METHODS: The 1-day blood pressure study included a history and physical examination by a physician, and measurements of serum sodium, potassium, creatinine, thyroxine, thyroid stimulating hormone, stimulated plasma renin activity, blood pressure response to the angiotensin II analogue saralasin, recumbent and upright plasma catecholamines, and plasma cortisol and aldosterone after infusion of 2 liters 0.9% saline over 3-4 h. RESULTS: The prevalence of secondary forms of hypertension was 10.2%, including renovascular hypertension (3.1%), primary aldosteronism (1.4%), Cushing's syndrome (0.5%), pheochromocytoma (0.3%), primary hypothyroidism (3.0%) and a serum creatinine > 2.0 mg/dl (1.8%). There was a very significantly increased prevalence with age of secondary forms of hypertension associated with renovascular hypertension, primary hypothyroidism and renal insufficiency. The concomitant presence of atherosclerosis significantly increased the prevalence of renovascular hypertension (9.5%) and renal insufficiency (8.0%). CONCLUSIONS: Increasing age and coexisting atherosclerosis have significant effects on the prevalence of secondary forms of hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Screening studies of patients with hypertension reported a 0.5-1% prevalence of Cushing's syndrome (36,37).”
From The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. (2008) · cites this paper as [36]
In the citing paper
“Among a series of 4494 patients referred to hypertension specialty clinics, 12.7% had secondary causes overall, of which 35% were associated with occlusive renovascular disease.306”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [306]
In the citing paper
“The MCA plus POTS group had higher systolic blood pressures compared with POTS and normal control groups.”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [127]
In the citing paper
“One study compared POTS patients with mast cell activation symptoms (flushing, shortness of breath, headache, lightheadedness, excessive diuresis, and gastrointestinal symptoms) and elevated urine N-methylhistamine to POTS patients with episodic flushing but normal urine methylhistamine127. Heart rate responses to upright posture were similar in both groups and were increased similarly as compared”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [127]
In the citing paper
“No differences were found in catecholamine levels between POTS with or without MCA symptoms.”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [127]
Citations
Cites
Still being checked.
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“5–1% prevalence of Cushing’s syndrome (36, 37).”
Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., White, A., Cushman, W. C., White, W., Sica, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,237
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Metadata
- Authors
- Anderson, G. H., Blakeman, N., & Streeten, D. H. P.
- Affiliations
- State University of New York (US)
- Venue
- Journal of Hypertension
- Published
- 1994-05
- Volume
- 12
- Issue
- 5
- Pages
- 609
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1999826744
- Cited by
- 403
- References
- 0
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 13 · 2022: 15 · 2021: 13 · 2020: 24 · 2019: 14 · 2018: 16 · 2017: 22 · 2016: 14 · 2015: 13 · 2014: 23 · 2013: 18 · 2012: 22
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-03055)
- National Heart, Lung, and Blood Institute (HL-26748)
- National Center for Research Resources (RR229)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
- Keywords
- secondary hypertension, age, prevalence, renovascular hypertension, primary aldosteronism, Cushing's syndrome, pheochromocytoma, primary hypothyroidism, renal failure, atherosclerosis, 24-hour ambulatory blood pressure monitoring, plasma renin activity, plasma aldosterone, plasma catecholamines, plasma cortisol
- MeSH terms
- Adrenal Gland Neoplasms, Cushing Syndrome, Female, Humans, Hyperaldosteronism, Hypertension, Hypothyroidism, Kidney Failure, Chronic, Male, Middle Aged, Pheochromocytoma, Referral and Consultation, Prevalence, Age Distribution, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. https://app.cochat.ai/papers/10.1097/00004872-199405000-00015
- The paper
- Anderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994). The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. Journal of Hypertension. https://doi.org/10.1097/00004872-199405000-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.